The diagnostic rate of inherited metabolic disorders by exome sequencing in a cohort of 547 individuals with developmental disorders

Affiliation auteurs!!!! Error affiliation !!!!
TitreThe diagnostic rate of inherited metabolic disorders by exome sequencing in a cohort of 547 individuals with developmental disorders
Type de publicationJournal Article
Year of Publication2021
AuteursDelanne J, Bruel A-L, Huet F, Moutton S, Nambot S, Grisval M, Houcinat N, Kuentz P, Sorlin A, Callier P, Jean-Marcais N, Mosca-Boidron A-L, Mau-Them FTran, Denomme-Pichon A-S, Vitobello A, Lehalle D, Chehadeh SEl, Francannet C, Lebrun M, Lambert L, Jacquemont M-L, Gerard-Blanluet M, Alessandri J-L, Willems M, Thevenon J, Chouchane M, Darmency V, Fatus-Fauconnier C, Gay S, Bournez M, Masurel A, Leguy V, Duffourd Y, Philippe C, Feillet F, Faivre L, Thauvin-Robinet C
JournalMOLECULAR GENETICS AND METABOLISM REPORTS
Volume29
Pagination100812
Date PublishedDEC
Type of ArticleArticle
Mots-clésdevelopmental delay, exome sequencing, Genotype first, Inherited metabolic disorders, intellectual disability
Résumé

Considering that some Inherited Metabolic Disorders (IMDs) can be diagnosed in patients with no distinctive clinical features of IMDs, we aimed to evaluate the power of exome sequencing (ES) to diagnose IMDs within a cohort of 547 patients with unspecific developmental disorders (DD). IMDs were diagnosed in 12% of individuals with causative diagnosis (177/547). There are clear benefits of using ES in DD to diagnose IMD, particularly in cases where biochemical studies are unavailable. Synopsis: Exome sequencing and diagnostic rate of Inherited Metabolic Disorders in individuals with develop-mental disorders.

DOI10.1016/j.ymgmr.2021.100812